Skip to content

Anti- glycation effect of "AG herb MIX" -containing food intake - A randomized, double blind, placebo-controlled study -

Anti- glycation effect of "AG herb MIX" -containing food intake - A randomized, double blind, placebo-controlled study - - Anti- glycation effect of "AG herb MIX" intake

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000015242
Enrollment
22
Registered
2014-09-24
Start date
2014-09-25
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

middle-aged female

Interventions

Ingestion of a capsule including AG herb MIX once a day in fasting for 12 weeks Ingestion of a placebo capsule including AG herb MIX once a day in fasting for 12 weeks

Sponsors

Karada Lab, Inc.
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Healthy Japanese women ages 45 or more and less than 65 years old

Exclusion criteria

Exclusion criteria: 1)Diabetics receiving medication or who need treatment 2)Persons with food allergy 3)Patients with a history of serious liver, renal or heart disease 4)Persons with the skin chronic disease including atopic dermatitis 5)Smoking persons 6)Persons with less than five hours in mean sleep 7)Users of anti-glycation foods or cosmetics 8)Users of foods or supplements affecting blood glucose 9)Patients who might affect the test values during the study due to chronic diseases or acute diseases 10)Patients with food or medicine allergies 11)Patients who had surgery of the digestive tract 12) Patients suspected of chronic or acute infectious diseases 13) Persons with high BMI more than 30 14)Persons who participated in other clinical trials within one month before start of this examination 15)Persons who have a difficulty in keeping their habits and customs 16)Persons who have a difficulty keeping a life diary 17)During the pregnancy or persons nursing and persons who may be pregnant 18)Persons who had donated > 200 mL of blood within 1 month or > 400 mL within 3 months prior to the study 19)Persons who work for anti-glycation foods related companies, or persons who have family members working for such companies 20)Persons who may eat or drink too much during this trial , or who have a habit of eating out 21)Persons who have been judged to be inappropriate for the study by a human medical trial supervisor

Design outcomes

Primary

MeasureTime frame
Skin elasticity, skin carboxymethylysine, skin AGEs accumulation, carboxymethylysine, 3-deoxyglucosone

Secondary

MeasureTime frame
skin color, skin image analysis by VISIA, fasting plasma glucose, HbA1c, insulin, questionnaire( the Anti-Aging QOL Common Questionnaire, skin questionnaire)

Countries

Japan

Contacts

Public ContactHiroshige Kawai

Karada Lab, Inc. no division

kawaih@arkray.co.jp050-5830-0973

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026